Edwards Lifesciences Corp Investing Cash Flow 2008-2026 | EW
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is Edwards Lifesciences Corp's current investing cash flow?
Edwards Lifesciences Corp (EW) annual investing cash flow for 2025 was $-712.9M, a 130.82% decline from 2024. Edwards Lifesciences Corp investing cash flow for the quarter ending March 31, 2026 was $-92.8M.
What was Edwards Lifesciences Corp's investing cash flow in 2024?
Edwards Lifesciences Corp annual investing cash flow for 2024 was $2.31B, a 1230.78% increase from 2023.
What was Edwards Lifesciences Corp's investing cash flow in 2023?
Edwards Lifesciences Corp annual investing cash flow for 2023 was $173.8M, a 31.11% decline from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-531.1M
→
FY2025
$-712.9M
080910111213141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-712.9M | -130.8% | 10-K |
| FY2024 | $2.31B | +1230.8% | 10-K |
| FY2023 | $173.8M | -31.1% | 10-K |
| FY2022 | $252.3M | +114.6% | 10-K |
| FY2021 | $-1.72B | -224.3% | 10-K |
| FY2020 | $-531.1M | +10.9% | 10-K |
| FY2019 | $-595.8M | -876.8% | 10-K |
| FY2018 | $76.7M | +111.9% | 10-K |
| FY2017 | $-647.2M | -205.7% | 10-K |
| FY2016 | $-211.7M | +33.0% | 10-K |
| FY2015 | $-316.1M | +50.1% | 10-K |
| FY2014 | $-633.0M | -53.4% | 10-K |
| FY2013 | $-412.7M | -423.7% | 10-K |
| FY2012 | $-78.8M | +80.6% | 10-K |
| FY2011 | $-406.5M | -561.0% | 10-K |
| FY2010 | $-61.5M | -253.4% | 10-K |
| FY2009 | $40.1M | -31.8% | 10-K |
| FY2008 | $58.8M | - | 10-K |
Company: Edwards Lifesciences CorpTicker: EWSector: OtherIndustry: Orthopedic, Prosthetic & Surgical Appliances & SuppliesView company profile →